Business Monitor International, Dec 2010, Pages: 107
The RomaniaPharmaceuticals and HealthcareReport provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies
Business Monitor International, Sep 2011, Pages: 114
Business Monitor International's (BMI) RomaniaPharmaceuticals and HealthcareReport (Q4 2011) provides industry professionals and strategists, corporate analysts, pharmaceutical associations
Business Monitor International, Dec 2007, Pages: 76
The RomaniaPharmaceuticals and HealthcareReport provides independent forecasts and competitive intelligence on Romaniaspharmaceuticals and healthcare industry.
Romania has benefited from
Business Monitor International, Sep 2010, Pages: 84
Business Monitor International's Greece Pharmaceuticals and HealthcareReport provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments
Business Monitor International, Nov 2010, Pages: 89
- GlaxoSmithKline
- Novartis
- Sanofi-Aventis
- Merck & Co Jordan Pharmaceuticals and HealthcareReportQ1 2011
Business Monitor International, March 2009, Pages: 76
increasingly spread to new, low cost bases, such as Romania. Furthermore, the weakening of the sterling has seen a major parallel export market Executive Summary
Greece Pharmaceuticals And Healthcare Industry
Business Monitor International, Oct 2007, Pages: 62
The Greece Pharmaceuticals and HealthcareReport provides independent forecasts and competitive intelligence on Greeces pharmaceuticals and healthcare industry.
The Greek pharmaceutical
Global Industry Analysts, Inc., Oct 2011, Pages: 977
, Carotenoids and others). Specific end-use segments also analyzed are Animal Feed Additives, Cosmetics, Food, and Pharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan
Business Monitor International, May 2010, Pages: 19
Report builds upon BMI’s expert Pharmaceuticals & Healthcare sector analysis to analyse the impact of Eurozone crisis on drug prices in the PIIGS pharmaceutical markets.
Fiscal Deficit Impact
